[1]马 涛.糖基化终末产物抑制剂对糖尿病并发症的影响[J].医学信息,2021,34(10):65-67，71.[doi:10.3969/j.issn.1006-1959.2021.10.018]
　MA Tao.The Effect of Inhibitors of Advanced Glycation End Products on the Complications of Diabetes[J].Medical Information,2021,34(10):65-67，71.[doi:10.3969/j.issn.1006-1959.2021.10.018]
点击复制

糖基化终末产物抑制剂对糖尿病并发症的影响()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年10期
页码:
65-67，71
栏目:
综述
出版日期:
2021-05-15

文章信息/Info

Title:
The Effect of Inhibitors of Advanced Glycation End Products on the Complications of Diabetes
文章编号:
1006-1959（2021）10-0065-04
作者:
马 涛
（天津北大医疗海洋石油医院肾内科，天津 300452）
Author(s):
MA Tao
(Department of Nephrology,Tianjin Peking University Medical Offshore Oil Hospital,Tianjin 300452,China)
关键词:
糖基化终末产物; 抑制剂; 糖尿病; 蛋白质非酶糖基化
Keywords:
Advanced glycosylation end products; Inhibitors; Diabetes; Protein non-enzymatic glycosylation
分类号:
R587
DOI:
10.3969/j.issn.1006-1959.2021.10.018
文献标志码:
A
摘要:
蛋白质非酶糖基化是蛋白质等大分子中的游离氨基与还原糖经过一系列的反应形成稳定的非酶糖基化终末产物（AGEs）的过程。过多的AGEs积累会改变蛋白质生理功能和理化性质，诱导促炎介质的表达，并进行氧化应激反应，造成细胞损伤，进一步导致糖尿病及其并发症的发生。阻断AGEs的形成可改善和预防糖尿病慢性并发症，这也为临床治疗糖尿病并发症提供了新的方向。本文主要就AGEs的特点、AGEs与糖尿病并发症以及抑制AGEs对糖尿病并发症的作用进行综述，以期为临床治疗糖尿病并发症提供参考依据。
Abstract:
Protein non-enzymatic glycosylation is a process in which free amino groups in protein and other macromolecules and reducing sugars undergo a series of reactions to form stable non-enzymatic glycosylation end products (AGEs).Excessive accumulation of AGEs will change the physiological functions and physical and chemical properties of proteins, induce the expression of pro-inflammatory mediators, and carry out oxidative stress response, causing cell damage, and further leading to the occurrence of diabetes and its complications.Blocking the formation of AGEs can improve and prevent chronic complications of diabetes, which also provides a new direction for clinical treatment of diabetes complications.This article mainly reviews the characteristics of AGEs, AGEs and diabetic complications, and the effect of inhibiting AGEs on diabetic complications, in order to provide a reference for clinical treatment of diabetic complications.

参考文献/References:

[1]Kouidrat Y,Zaitoun A,Amad A,et al.Skin auto fluorescence(a marker for advanced glycation end products)and erectile dysfunction in diabetes[J].Journal of Diabetes and Its Complications,2017,31(1):108-113.[2]刘言言,黄楷,郎江莉,等.晚期糖基化终末产物诱导糖尿病血管病变机制的初步探讨[J].中华血管外科杂志,2020,5(2):129-134. [3]张仁宇,任超,秦兴华,等.晚期糖基化终末产物对心血管损伤的机制及防治策略[J].心脏杂志,2017(2):241-245. [4]Wang B,Li N,Liu T,et al.Synthesis and biological evaluation of novel neoflavonoid derivatives as poten- tial antidiabetic agents[J].RSC Adv,2017,7(55):34448-34460．[5]张军,张琦,吴艳艳,等.黄芩素、氨基胍干预下糖尿病大鼠类表皮样生长因子结构蛋白-7脑组织表达变化的研究[J].中国糖尿病杂志,2017,25(3):272-276．[6]苏文,李虹伟,陈晖,等.糖基化终末产物损伤冠状动脉平滑肌细胞Kv通道[J].首都医科大学学报,2016,37(6):725-730．[7]Xu Y,Guo Y,Gao Y,et al.Seperation,characterization and inhibition on α-glucosidase，α-amylase and glycation of a polysaccharide from blackcurrant fruits[J].LWT,2018,93(7):16-23．[8]甄东户,刘丽娟,成建国,等．二甲双胍对糖基化终末产物诱导的成骨细胞氧化应激和凋亡的影响[J].中国临床药理学与治疗学,2014,8(7):743-748.[9]唐丽霞,朱开梅,李典鹏,等．槲皮素脂质体对糖尿病大鼠肾脏糖基化终产物及其受体表达的影响[J].天津医药,2016,44(1):71-74．[10]Mohan S,Nandhakumar L.Role of various flavonoids:Hypotheses on novel approach to treat diabetes[J].Journal of Medical Hypotheses and Ideas,2014,8(1):1-6.[11]高柳.晚期糖基化终产物及其受体在2型糖尿病性骨质疏松症中的作用[D].河北医科大学,2016．[12]王爱华.白藜芦醇对血管内皮细胞糖基化损伤的保护作用[D].山东大学,2014.[13]Wang L,Zhang B,Xiao J,et al.Physicochemical，functional，and biological properties of water-soluble polysaccharides from Rosa roxburghii Tratt fruit[J].Food Chemistry,2018,249(5):127-135．[14]李子卿,王海兴,何沛恒,等.晚期糖基化终末产物可影响破骨细 胞的骨吸收功能[J].中国组织工程研究,2016,20(20):2907-2914. [15]丁志民,王珏,王东苗,等.晚期糖基化终末产物与炎症性骨破坏[J].口腔生物医学,2015,4(1):48-51．[16]段懿涵,徐健,卢学春,等.鸡腿菇多糖对链脲佐菌素诱导糖尿病大鼠的降血糖作用[J].中国比较医学杂志,2019,29(12):76-81.[17]张良栓,童想柳,张一佳,等.苦参多糖维持红细胞氧化还原平衡作用[J].黑龙江大学自然科学学报,2017,34(2):213-217.[18]李新萍,周书琦,徐丽丽,等.山药多糖的提取及其对糖尿病小鼠的影响研究[J].黑龙江医药,2018,31(1):20-22.[19]陈莉明.噻唑烷二酮类药物治疗2型糖尿病的临床认识[J].中国实用内科杂志,2015,34（10）:947-951．[20]袁良玉,江莉,周扬,等.牛血清白蛋白残留量检测试剂盒内部参考品的制备及标定[J].国际生物制品学杂志,2019,42(4):189-192.[21]庞若龙,关美萍,郑宗基,等.二甲双胍对糖基化终末产物诱导的成纤维细胞凋亡及相关蛋白caspase-3、Bax 及 Bcl-2 表达的影响[J].南方医科大学学报,2015,35(6):898-902.[22]曾理.黄酮类化合物对α-葡萄糖苷酶和非酶糖基化的抑制作用研究[D].南昌大学,2017. [23]陈天晴.膳食多酚抑制α-葡糖苷酶活性的构效关系研究[D].上海师范大学,2018.[24]蔡建秀,董文云,黄晓冬,等.桐花树根多酚提取物体外α-糖苷酶抑制活性与抗氧化能力[J].中国医院药学杂志,2015,35(24):2193-2196.[25]卞宇婷,卢晓宇,王丽华.多酚类化合物的生物学活性及其在心脑血管疾病中的保护性作用研究[J].脑与神经疾病杂志,2020,28(10):649-654.[26]Bord J,Forbes JM.Targeting advanced glyca- tion with pharmaceutical agents:where are we now[J].Glycoconj J,2016,33(4):653-670．[27]刘银,苏笮斌,胡力文,等.某中药复方对早期糖尿病肾病大鼠肾组织肾素-血管紧张素系统的影响因素初探[J].现代预防医学,2018,45(11):2034-2038.[28]郎志芳,刘兰涛,王洪伟,等.绞股蓝对糖尿病肾病大鼠免疫功能的影响[J].中国现代药物应用,2019,13(7):235-237.[29]张军,张琦,吴艳艳,等.黄芩素、氨基胍干预下糖尿病大鼠类表皮样生长因子结构蛋白-7 脑组织表达变化的研究[J].中国糖尿病杂志,2017,25(3):272-276． [30]鲍涛.云南高寒山区苦荞黄酮抗氧化和降血糖活性研究[D].浙江大学,2017.[31]任锟,李彦杰,邢若星,等.槲皮素对非对称性二甲基精氨酸诱导损伤的脑血管内皮细胞的保护作用及其机制研究[J].中国脑血管病杂志,2019,16(2):82-88.[32]薛强,陈红,周佳丽,等.葛根素对局灶性脑缺血大鼠半暗带微血管内皮细胞的保护作用及其机制[J].中国新药杂志,2019,28(2):151-158.[33]刘雪蕊.黄秋葵多糖的提取及其降血糖活性研究[D].天津科技大学,2017.[34]李雅婷.晚期糖基化终末产物(AGEs)在糖尿病胰岛β细胞凋亡中的作用和机制研究[D].南京医科大学,2016.[35]Salami M,Rahimmalek M,Ehtemam H.Inhibitory effect of different fennel(Foeniculum vulgare)samples and the，irphenolic compounds on formation of advanced glycation products and comparison of antimicrobial and antioxidant activities[J].Food Chemistry,2016(213):196-205.

相似文献/References:

[1]张文慧,高 丽,黄惠丽,等.蛋白磷酸酶1和2A的研究进展[J].医学信息,2018,31(15):20.[doi:10.3969/j.issn.1006-1959.2018.15.009]
　ZHANG Wen-hui,GAO Li,HUANG Hui-li,et al.Progress in the Research of Protein Phosphatase 1 and 2A[J].Medical Information,2018,31(10):20.[doi:10.3969/j.issn.1006-1959.2018.15.009]
[2]于祥菊,宋碧莹,刘 滢,等.Chk1及其抑制剂调控肿瘤作用机制研究[J].医学信息,2019,32(19):39.[doi:10.3969/j.issn.1006-1959.2019.19.013]
　YU Xiang-ju,SONG Bi-ying,LIU Ying,et al.Study on the Mechanism of Chk1 and Its Inhibitors Regulating Tumor[J].Medical Information,2019,32(10):39.[doi:10.3969/j.issn.1006-1959.2019.19.013]
[3]卢 琪,尹富生,兰 凯.PI3K/AKT/mTOR通路与胰腺癌发生发展及治疗的研究[J].医学信息,2025,38(02):184.[doi:10.3969/j.issn.1006-1959.2025.02.037]
　LU Qi,YIN Fusheng,LAN Kai.Role of PI3K/AKT/mTOR Pathway in the Development and Treatment of Pancreatic Cancer[J].Medical Information,2025,38(10):184.[doi:10.3969/j.issn.1006-1959.2025.02.037]

更新日期/Last Update: 1900-01-01